DroneShield’s Dual Dilemma: A Regulator’s Shadow and a Record Short Bet

DroneShield shares hit €1.28, down 28.75% YTD, as Jefferies cuts target, short interest spikes to 12.84%, and ASIC probes disclosures.

The counter-drone specialist DroneShield is navigating treacherous waters. Its shares closed at €1.28 on Friday, marking a 5.52% single-day decline and a fresh six-month trough. The stock has now shed 28.75% of its value since the start of the year, a slide that has accelerated as a confluence of regulatory uncertainty, analyst downgrades, and aggressive short-selling weighs heavily on investor sentiment.

The latest blow came from Jefferies, which slashed its price target by 27% to A$2.05. The investment bank cut its revenue forecasts for the 2026 through 2028 period by roughly 9%, while earnings-per-share estimates were trimmed by between 5% and 16%, depending on the timeframe. The revision adds to a growing pile of headwinds for a company that had previously enjoyed a stellar run.

Short sellers have been circling with increasing conviction. The cumulative short position in DroneShield has ballooned by 7.01 million shares since July 1, pushing the short interest to approximately 12.84% of outstanding shares — the highest level in a year. With the total share count holding steady at around 924.1 million, the proportion of borrowed stock in free float has risen sharply, making DroneShield one of the most heavily shorted names on the Australian Securities Exchange.

On the other side of the trade, Fidelity has been quietly building a larger stake. FMR LLC, the parent of the asset management giant, increased its voting rights from 8.84% to 9.93% between March 24 and July 16, adding over 10.1 million shares to its portfolio during that stretch. The move positions the fund as a formidable counterweight to the bearish bets piling up against the stock.

Adding a layer of complexity is JPMorgan Chase. The bank had fallen off the list of reportable major shareholders in early May after its stake dipped below the 5% threshold. On July 17, it reappeared with a freshly disclosed voting rights position of 5.15%, equivalent to 47,558,252 ordinary shares. The twist: more than half of that holding — 25,294,918 shares — is tied up in securities lending, where JPMorgan acts as an intermediary. This lending activity effectively supplies ammunition to short sellers, creating a structural irony where a large institutional presence simultaneously enables the very bets that are dragging the stock lower.

The technical picture offers little comfort. The share price now sits 21.01% below its 50-day moving average, a gap that typically signals an entrenched downtrend with no immediate reversal in sight. The relative strength index has dipped to 34.3, approaching oversold territory, while the annualized 30-day volatility stands at a jittery 67.63%, pointing to continued sharp swings ahead.

Perhaps the most persistent overhang is the regulatory probe. The Australian Securities and Investments Commission is examining disclosures and share transactions from November 2025, specifically announcements made between November 1 and 20, and trading activity between November 6 and 12. The investigation centers on a mistakenly published and later retracted announcement regarding an order package valued at A$7.6 million. DroneShield later clarified that the figure referred to already known, reissued orders rather than new business. The company has stated it is cooperating fully with the regulator, but the lack of resolution continues to sap investor confidence.

Operationally, the picture is more encouraging. In May, the ASX exempted DroneShield from quarterly activity and cash flow reporting after four consecutive quarters of positive operating cash flow, effectively upgrading the company to the reporting standards of established, profitable firms. Under CEO Angus Bean, who took the helm in April, the company secured a US$24.9 million contract with the US Joint Interagency Task Force 401 in June. Yet these milestones have done little to arrest the stock’s decline, suggesting that market sentiment is more tightly tethered to the regulatory outcome than to operational wins.

All eyes are now on the first-half results for fiscal 2026, due on September 1. Until then, the stock is likely to remain highly sensitive to fresh short-interest data, further analyst revisions, and any update from the ASIC investigation. For bulls and bears alike, the next few weeks will be decisive.